» Articles » PMID: 3011873

Toluene Diisocyanate-induced Airway Hyperreactivity and Pathology in the Guinea Pig

Overview
Date 1986 Jun 1
PMID 3011873
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

We assessed the nature and progression of airway mucosal disease and histaminic reactivity in English short-haired guinea pigs at 2, 24, 72, 168, and 504 hours after toluene diisocyanate (TDI) exposure (4 hours of 3 ppm of TDI for 5 consecutive days). To also determine whether TDI-specific, IgE-like antibodies developed in TDI-exposed animals, passive cutaneous anaphylaxis testing was done 28 days after TDI. Bronchial reactivity was determined serially by measuring specific airway conductance as a function of increasing doses of aerosolized histamine in six exposed and three control animals studied intact and unanesthetized. The remaining 10 exposed and 10 control guinea pigs were sacrificed in groups of two at each time point to obtain airway tissue for light microscopic examination. We found that airway hyperreactivity to histamine occurred after TDI in all animals tested. It was maximal 2 hours after the 5-day exposure and remitted by 72 hours. In addition, marked airway obstruction occurred after TDI that persisted for at least 168 hours. There were dramatic signs of airway mucosal damage associated with the bronchial hyperreactivity that included substantial decreases in epithelial cilia, mucin content, and mast cells, as well as squamous metaplasia, numerous mitotic figures, and a prominent polymorphonuclear leukocytic infiltrate. Passive cutaneous anaphylaxis tests in exposed animals were negative. Our results suggest that TDI-induced bronchial hyperreactivity may be related to airway mucosal injury and inflammation.

Citing Articles

Ultrastructure of Highly Ordered Granules in Alveolar Type II Cells in Several Species.

Miller M, Porollo A, Wert S Anat Rec (Hoboken). 2018; 301(7):1290-1302.

PMID: 29544026 PMC: 6139087. DOI: 10.1002/ar.23805.


Toluene diisocyanate increases airway responsiveness to substance P and decreases airway neutral endopeptidase.

Sheppard D, Thompson J, Scypinski L, Dusser D, Nadel J, Borson D J Clin Invest. 1988; 81(4):1111-5.

PMID: 2450892 PMC: 329638. DOI: 10.1172/JCI113424.